The new therapeutic domain is hybrid chains. Such engineered compounds integrate portions from multiple peptide families, facilitating the development of unique therapeutic properties. This strategy provides a exciting https://chimerapeptides495881.judgeblog.com/62015897/chimera-peptides-a-novel-therapeutic-frontier